Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02848586 · ClinicalTrials.gov registry record · NA
Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02848586 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 10 participants.
The verdict
NCT02848586, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if using e-cigarettes (ECIG) rather than regular tobacco cigarettes alters lung inflammation in people with and without HIV. The study is also interested in asking subjects their opinion on the use of ECIG and how they make them feel. This study is for research purposes only and is not intended to treat asthma or HIV or to modify tobacco use.
Interventions
- BEHAVIORAL mobile contingency management (mCM)
- OTHER ECIGS
- OTHER Usual brand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02848586
The ClinicalTrials.gov registry entry for NCT02848586 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which mobile contingency management (mCM) is the first listed.
NCT02848586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02848586 about?
NCT02848586 is a clinical study titled "Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers". The purpose of this study is to determine if using e-cigarettes (ECIG) rather than regular tobacco cigarettes alters lung inflammation in people with and without HIV. The study is also interested in asking subjects their opinion on the use of ECIG and how they make them feel. This study is for resea...
What is the current status of trial NCT02848586?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2016-08. Estimated completion is 2018-05-08.
What interventions are being tested in trial NCT02848586?
The interventions under investigation include: mobile contingency management (mCM) (BEHAVIORAL), ECIGS (OTHER), Usual brand (OTHER).
Who is sponsoring clinical trial NCT02848586?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.